Growth Factors and Receptors in Juvenile Nasopharyngeal Angiofibroma and Nasal Polyps: An Immunohistochemical Study

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 11, 2003, Pages 1480-1484

  Zhang, Paul J ^a   Weber, Randal ^a   Liang, Ho Hi ^a   Pasha, Teresa L ^a   LiVolsi, Virginia A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR; PROTEIN P130; SOMATOMEDIN C RECEPTOR; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA3; BCAR1 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; CRK ASSOCIATED SUBSTRATE PROTEIN; GROWTH PROMOTOR; MEMBRANE ANTIGEN; PARAFFIN; PHOSPHOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN; RETINOBLASTOMA PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HEMANGIOFIBROMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE NASOPHARYNGEAL ANGIOFIBROMA; MALE; PROTEIN EXPRESSION; STROMA CELL; BIOSYNTHESIS; CHEMISTRY; IMMUNOLOGY; METHODOLOGY; NASOPHARYNX TUMOR; NOSE POLYP; PATHOLOGY;

ADOLESCENT; ADULT; ANGIOFIBROMA; ANTIGENS, SURFACE; BONE MORPHOGENETIC PROTEINS; CHILD; CRK-ASSOCIATED SUBSTRATE PROTEIN; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NASAL POLYPS; NASOPHARYNGEAL NEOPLASMS; NERVE GROWTH FACTOR; PARAFFIN EMBEDDING; PHOSPHOPROTEINS; PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, IGF TYPE 1; RECEPTORS, PROGESTERONE; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P130; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

EID: 0242335688     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Neel HB, Whicker JH, Devine KD, Weiland LH. Juvenile angiofibroma: review of 120 cases. Am J Surg. 1973;126:547-556.
2. McGavran MH, Dorfman RF, Davis DO, Ogura JH. Nasopharyngeal angiofibroma. Arch Otolaryngol. 1969;96:68-78.
3. Twefik TL, Tan AKW, Al Noury K, et al. Juvenile nasopharyngeal angiofibroma. J Otolaryngol. 1999;28:145-151.
4. Mills SE, Gaffey MJ, Frierson HF Jr. Nasopharyngeal angiofibroma. In: Rosai J, Sobin LH, eds. Tumors of the Upper Aerodigestive Tract and Ear. Washington, DC: Armed Forces Institute of Pathology; 2000:252-257. Atlas of Tumor Pathology; 3rd series, fascicle 26.
5. Mills SE, Gaffey MJ, Frierson HF Jr. Nasopharyngeal angiofibroma. In: Rosai J, Sobin LH, eds. Tumors of the Upper Aerodigestive Tract and Ear. Washington, DC: Armed Forces Institute of Pathology; 2000:252-257. Atlas of Tumor Pathology; 3rd series, fascicle 26
6. McCombe A, Lund VJ, Howard DJ. Recurrence in juvenile angiofibroma. Rhinology. 1990;28:97-102.
7. Hubbard EM. Nasopharyngeal angiofibroma. Arch Otolaryngol. 1958;65: 192-204.
8. Lee DE, Rao BR, Meyer JS, Prioleau PG, Bauer WC. Hormonal receptor determination in juvenile nasopharyngeal angiofibroma. Cancer. 1980;46:547-551.
9. Schiff M. Juvenile nasopharyngeal angiofibroma. Laryngoscope. 1959;69: 981-987.
10. Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11:1122-1126.
11. Farag MM, Ghanimah SE, Ragaie A, Saleem TH. Hormonal receptors in juvenile nasopharyngeal angiofibroma. Laryngoscope. 1987;97:208-211.
12. Brentani MM, Butugan O, Oshima CT, Torloni H, Paiva LJ. Multiple steroid receptors in nasopharyngeal angiofibroma. Laryngoscope. 1989;99:398-401.
13. Gates GA, Rice DH, Koopmann DF, Schuller DE. Flutamide-induced regression of angiofibroma. Laryngoscope. 1992;102:641-644.
14. Johns ME, Macleod RM, Cantrell RW. Estrogen receptors in nasopharyngeal angiofibroma. Laryngoscope. 1980;90:628-634.
15. Panetti TS. Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration. Front Biosci. 2002;7:143-150.
16. Yi J, Kloeker S, Jensen CC, et al. Members of the Zyxin family of LIM proteins interact with members of the p130 Cas family of signal transducers. J Bio Chem. 2002;277:9580-9589.
17. van der Flier S, Chan CM, Brinkman A, et al. BCAR/130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas. Int J Cancer. 2000;89:465-468.
18. Brinkman A, van der Flier S, Kok EM, Dorssers LC. BCAR1, a human homologue of the adapter protein p130Cas and antiestrogen resistance in breast cancer cells. J Natl Cancer Inst. 2000;92:112-120.
19. Morin PJ. β-catenin signaling and cancer. Bioessays. 1999;21:1021-1030.
20. Giardiello FM, Hamilton SR, Krush AJ, Offerhaus JA, Booker SV, Petersen GM. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology. 1993;105:1550-1552.
21. Ferouz AS, Mohr RM, Paul P. Juvenile nasopharyngeal angiofibroma and familial adenomatous polyposis: an association? Otolaryngol Head Neck Surg. 1995;113:435-439.
22. Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent β-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol. 2001;158: 1073-1078.
23. Guertl B, Beham A, Zachner R, Stammberger H, Hoefler G. Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol. 2000;31:1411-1413.
24. Nagai MA, Butugan O, Logullo A, Brentani MM. Expression of growth factors, proto-oncogenes, and p53 in nasopharyngeal angiofibromas. Laryngoscope. 1996;106:190-195.
25. Dillard DG, Cohen C, Muller S, et al. Immunolocalization of activated transforming growth factor beta 1 in juvenile nasopharyngeal angiofibroma. Head Neck Surg. 2000;126:723-725.
26. Mendelsohn J, Baird A, Zhen F, Markowitz SD. Growth factors and their receptors in epithelial malignancies. In: Mendelsohn AC, Mowley A, Israel SJ, Liotta L, eds. The Molecular Basis of Cancer. 2nd ed. Philadelphia, Pa: WB Saunders; 2001:144-145.
27. Cohen MM. Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and NOGGIN. Am J Med Genet. 2002;109: 87-92.
28. Dooley CA, Attia GR, Rainey WE, Moore DR, Carr BR. Bone morphogenetic protein inhibits ovarian androgen production. J Clin Endocrinol Metab. 2000;85:3331-3337.
29. Guo W, Gorlick R, Ladanyi M, et al. Expression of bone morphogenetic proteins and receptors in sarcomas. Clin Orthop. 1999;365:175-183.
30. Yarden Y, Kuang WS, Yang-Feng T, et al. Human proto-oncogene, c-Kit, a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987;6:3341-3351.
31. Matsuda R, Takahashi T, Nakamura S, et al. Expression of the c-Kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol. 1993;142:339-346.
32. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001;344:1052-1056.
33. Joensuu H, Dimitrijevic S. Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumours. Ann Med. 2001;33:451-455.
34. Sawada J, Itakura A, Tanaka A, Furusaka T, Matsuda H. Nerve growth factor function as a chemoattractant for mast cells through both mitogen activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood. 2000; 95:2052-2058.
35. Raychaudhuri SK, Raychaudhuri SP, Weltman H, Farber EM. Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res. 2001;293:291-295.
36. Olgart C, Frossard N. Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur Respir J. 2001;18:115-121.
37. Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett. 2001;169:107-114.
38. Mills SE, Gaffey MJ, Frierson HF Jr. Nasopharyngeal angiofibroma. In: Rosai J, Sobin LH, eds. Tumors of the Upper Aerodigestive Tract and Ear. Washington, DC: Armed Forces Institute of Pathology; 2000:355-357. Atlas of Tumor Pathology, 3rd series, fascicle 26.
39. Mills SE, Gaffey MJ, Frierson HF Jr. Nasopharyngeal angiofibroma. In: Rosai J, Sobin LH, eds. Tumors of the Upper Aerodigestive Tract and Ear. Washington, DC: Armed Forces Institute of Pathology; 2000:355-357. Atlas of Tumor Pathology, 3rd series, fascicle 26
40. Frazer JP. Allergic rhinitis and nasal polyps. Ear Nose Throat J. 1984;63: 172-176.
41. Scobie JV, Acs G, Bandera CA, et al. C-kit immunoreactivity in endometrial adenocarcinomas and its clinicopathologic significance. Int J Gynecol Pathol. 2003;22:149-155.
42. Acs G, Zhang PJ, McGrath CM, et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol. 2003;162:1789-1806.